跳至主要内容
临床试验/NCT02347878
NCT02347878Unknown4 期

Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
85
试验地点
1
主要终点
incidence of any grade post-lumbar-puncture headache

研究概览

简要总结

Headache following a lumbar puncture (post-lumbar-puncture headache,PLPH)is a common and often debilitating syndrome, which was reported to occur in about 40% patients who received lumbar puncture. Now there lacks of effective approaches in the prophylaxis of PLPH, although some physicians consider bed rest for at least 6 hours to be a useful methods (Some recent meta-analysis found no benefit of bed rest for any hours in the prevention of PLPH). Studies have found that P substances and its receptor (Neurokinin-1 receptor, NK-1R)have played an important role in the pathogenesis of PLPH. Thus, we hypothesize that use of NK-1R inhibitor (aprepitant) 1 hour before lumbar puncture may decrease the incidence of PLPH and lower the severity of PLPH.

详细描述

Headache following a lumbar puncture (post-lumbar-puncture headache,PLPH)is a common and often debilitating syndrome, which was reported to occur in about 40% patients who received lumbar puncture. Now there lacks of effective approaches in the prophylaxis of PLPH, although some physicians consider bed rest for at least 6 hours to be a useful methods (Some recent meta-analysis found no benefit of bed rest for any hours in the prevention of PLPH). Studies have found that P substances and its receptor (Neurokinin-1 receptor, NK-1R)have played an important role in the pathogenesis of PLPH. Thus, we hypothesize that use of NK-1R inhibitor (aprepitant) 1 hour before lumbar puncture may decrease the incidence of PLPH and lower the severity of PLPH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed as acute leukemia, or lymphoma
  • Patients will received repeated lumbar puncture (at least 2 times, and at least 2 weeks apart) and intrathecal treatment
  • Without CNS involvement
  • Without headache for at least 1 week before the day of lumbar puncture
  • The platelet count was at least 30×10e9/L

排除标准

  • With CNS involvement of disease
  • With headache before lumbar puncture
  • Needs lumbar puncture more than once a week

研究组 & 干预措施

treatment arm

Experimental

this treatment arm will received aprepitant 1 hour before lumbar puncture and intrathecal treatment.

干预措施: Aprepitant (Drug)

结局指标

主要结局

incidence of any grade post-lumbar-puncture headache

时间窗: date from the day of lumbar puncture to 2 weeks after lumbar puncture

次要结局

  • incidence of grade 3/4 post-lumbar-puncture headache(date from the day of lumbar puncture to 2 weeks after lumbar puncture)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liang Wang

Doctor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验